SALL2 and neoplasm: Our findings support a tumor suppressor role for SALL2 in colorectal cancer, mediated in part through a previously unrecognized SALL2-dependent regulatory mechanism involving AXIN2, a key negative modulator of Wnt/β-catenin signaling.